Treating high density lipoprotein cholesterol (HDL-C): Quantity versus quality
Low density lipoproteins (LDL) and high density lipoproteins (HDL) are independent risk factors for coronary heart disease (CHD); decreasing LDL-cholesterol (LDL-C) levels with statin therapy represents the primary goal in the management of cardiovascular disease. However, despite the efficacy of st...
| Main Authors: | , , |
|---|---|
| Format: | Journal Article |
| Published: |
2013
|
| Online Access: | http://hdl.handle.net/20.500.11937/55177 |
Similar Items
HDL: To treat or not to treat?
by: Pirillo, A., et al.
Published: (2014)
by: Pirillo, A., et al.
Published: (2014)
Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials
by: Catapano, A., et al.
Published: (2017)
by: Catapano, A., et al.
Published: (2017)
High-density lipoprotein subfractions - What the clinicians need to know
by: Pirillo, A., et al.
Published: (2013)
by: Pirillo, A., et al.
Published: (2013)
Biology of proprotein convertase subtilisin kexin 9: Beyond low-density lipoprotein cholesterol lowering
by: Norata, Giuseppe, et al.
Published: (2016)
by: Norata, Giuseppe, et al.
Published: (2016)
HDL in infectious diseases and sepsis
by: Pirillo, A., et al.
Published: (2015)
by: Pirillo, A., et al.
Published: (2015)
Emerging role of high density lipoproteins as a player in the immune system
by: Norata, Giuseppe, et al.
Published: (2012)
by: Norata, Giuseppe, et al.
Published: (2012)
HDL in innate and adaptive immunity
by: Catapano, A., et al.
Published: (2014)
by: Catapano, A., et al.
Published: (2014)
High density lipoproteins and atherosclerosis: Emerging aspects
by: Sala, F., et al.
Published: (2012)
by: Sala, F., et al.
Published: (2012)
The missing link between high-density lipoprotein cholesterol and inflammatory response in cardiovascular disease
by: Ammirati, E., et al.
Published: (2014)
by: Ammirati, E., et al.
Published: (2014)
High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease
by: Baragetti, A., et al.
Published: (2013)
by: Baragetti, A., et al.
Published: (2013)
Novel concepts in HDL pharmacology
by: Remaley, A., et al.
Published: (2014)
by: Remaley, A., et al.
Published: (2014)
The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
by: Pirillo, A., et al.
Published: (2018)
by: Pirillo, A., et al.
Published: (2018)
HDL and adaptive immunity: A tale of lipid rafts
by: Norata, Giuseppe, et al.
Published: (2012)
by: Norata, Giuseppe, et al.
Published: (2012)
Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy?
by: Catapano, A., et al.
Published: (2017)
by: Catapano, A., et al.
Published: (2017)
Therapy and clinical trials: Aggressive statin therapy versus combined and emerging approaches
by: Catapano, A., et al.
Published: (2011)
by: Catapano, A., et al.
Published: (2011)
Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases?
by: Nakamura, K., et al.
Published: (2009)
by: Nakamura, K., et al.
Published: (2009)
Heterozygous mthfr c677t polymorphism (rs1801133) is associated with higher total cholesterol/ high density lipoprotein cholesterol ratio in habitual coffee drinkers
by: Ong, Xuan
Published: (2023)
by: Ong, Xuan
Published: (2023)
Apolipoprotein C-III: From Pathophysiology to Pharmacology
by: Norata, Giuseppe, et al.
Published: (2015)
by: Norata, Giuseppe, et al.
Published: (2015)
Niemann-pick C1-like 1 (NPC1L1) inhibition and cardiovascular diseases
by: Pirillo, A., et al.
Published: (2016)
by: Pirillo, A., et al.
Published: (2016)
Statins and periodontal inflammation: A pleiotropic effect of statins or a pleiotropic effect of LDL-cholesterol lowering?
by: Norata, Giuseppe, et al.
Published: (2014)
by: Norata, Giuseppe, et al.
Published: (2014)
MicroRNAs and lipoproteins: A connection beyond atherosclerosis?
by: Norata, Giuseppe, et al.
Published: (2013)
by: Norata, Giuseppe, et al.
Published: (2013)
Plasma triglyceride and high density lipoprotein cholesterol are poor surrogate markers of pro-atherogenic chylomicron remnant homeostasis in subjects with the metabolic syndrome
by: Irawati, D., et al.
Published: (2016)
by: Irawati, D., et al.
Published: (2016)
HDL and its subpopulation (HDL2 and HDL3) promote cholesterol transporters expression and attenuate inflammation in 3T3-L1 mature adipocytes induced by tumor necrosis factor-alpha
by: Suhaila Abd Muid,, et al.
Published: (2022)
by: Suhaila Abd Muid,, et al.
Published: (2022)
HDL and its subpopulation (HDL2 AND HDL3) promote cholesterol transporters expression and attenuate inflammation in 3t3-l1 mature adipocytes induced by tumor necrosis factor-alpha
by: Suhaila Abd Muid,, et al.
Published: (2022)
by: Suhaila Abd Muid,, et al.
Published: (2022)
TRAK2, a novel regulator of ABCA1 expression, cholesterol efflux and HDL biogenesis
by: Lake, N., et al.
Published: (2017)
by: Lake, N., et al.
Published: (2017)
Postprandial lipemia as a cardiometabolic risk factor
by: Pirillo, A., et al.
Published: (2014)
by: Pirillo, A., et al.
Published: (2014)
LOX-1, OxLDL, and atherosclerosis
by: Pirillo, A., et al.
Published: (2013)
by: Pirillo, A., et al.
Published: (2013)
HDLs, immunity, and atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2011)
by: Norata, Giuseppe, et al.
Published: (2011)
Strategies for the use of nonstatin therapies
by: Pirillo, A., et al.
Published: (2017)
by: Pirillo, A., et al.
Published: (2017)
Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: Patient selection and perspectives
by: Catapano, A., et al.
Published: (2017)
by: Catapano, A., et al.
Published: (2017)
Efficacy of Ganoderma lucidum on plasma lipids and lipoproteins in rats fed with high cholesterol diet
by: Tong, Chow Chin, et al.
Published: (2008)
by: Tong, Chow Chin, et al.
Published: (2008)
Factors associated with nonachievement of low density
lipoprotein cholesterol target among patients with type 2 diabetes mellitus
by: Mat Yudin, Zainab
Published: (2015)
by: Mat Yudin, Zainab
Published: (2015)
Status of oxidative stress biomarkers and lecithin cholesterol acyltransferanse (LCAT) gene variant in subjects with low HDL-c concentration / Farah Hanis Sakri
by: Sakri, Farah Hanis
Published: (2016)
by: Sakri, Farah Hanis
Published: (2016)
PCSK9 inhibition in statin-intolerant HeFH patients: What's new?
by: Casula, M., et al.
Published: (2017)
by: Casula, M., et al.
Published: (2017)
Proprotein Convertase Subtilisin-Kexin type-9 (PCSK9) and triglyceride-rich lipoprotein metabolism: Facts and gaps
by: Baragetti, A., et al.
Published: (2018)
by: Baragetti, A., et al.
Published: (2018)
Impact of systemic inflammation and autoimmune diseases on apoA-i and HDL plasma levels and functions
by: Montecucco, F., et al.
Published: (2015)
by: Montecucco, F., et al.
Published: (2015)
The structure and dynamics of plasma high-density lipoproteins and their interactions with the beta-amyloid peptide
by: Malajczuk, Chris
Published: (2022)
by: Malajczuk, Chris
Published: (2022)
Low density lipoprotein cholesterol phenotypes and their association with risk factors of cardiovascular disease among subjects attending health screening at a public university in Malaysia
by: Mazalan, Norlianah
Published: (2019)
by: Mazalan, Norlianah
Published: (2019)
Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: An individual participant data meta-analysis of 23 studies in the asia-pacific region
by: Huxley, Rachel, et al.
Published: (2011)
by: Huxley, Rachel, et al.
Published: (2011)
Oxidizes Low Density Lipoprotein Cytoxicity and Vascular Diseases
by: Gieseg, Steven P., et al.
Published: (2009)
by: Gieseg, Steven P., et al.
Published: (2009)